Anti-hEGFR

InvivoGen Kontakt z doradcą
Family of antibodies against human EGFR
Anti-hEGFR

The Anti-hEGFR isotype family features the variable region of cetuximab. Cetuximab is a chimeric human/mouse IgG1 monoclonal antibody that targets EGFR, a cell surface receptor overexpressed in many types of cancer. Binding of cetuximab to EGFR blocks ligand/receptor binding and induces receptor internalization and subsequent degradation. Cetuximab has been approved by the FDA for the treatment of metastatic colorectal cancer and metastatic squamous cell carcinoma of the head and neck.

InvivoGen's Anti-hEGFR isotype family has been generated by recombinant DNA technology, produced in CHO cells, and purified by affinity chromatography with protein G (IgG) or peptide M (IgA2).

Podobne produkty

H4-derived Anti-SARS-CoV-2 RBD mAbs

H4-derived Anti-SARS-CoV-2 RBD mAbs

InvivoGen
Więcej
Anti-hCD40L

Anti-hCD40L

InvivoGen
Więcej
Anti-hCD14

Anti-hCD14

InvivoGen
Więcej